ABEV
Ambev SA
$3.12
▲ 1.3%Updated Today 3:42 PM ET
ABEV at a glance — five pillars scored 0–100 from real filed financials.
Overall: Neutral · 57/100. A wider, greener shape means more pillars look healthy. Dividends scores 0 when a company pays none — that is a choice, not a flaw.
▲ Up 23.1% over the last 12 months
Market Cap
$51.34B
P/E
16.48x
Forward P/E (est.)
15.15x
ROE
17.2%
Revenue Growth
-3.8%
EPS Growth
8.8%
Profit Margin
17.7%
FCF Yield
—
Debt / Equity
0.04x
ROIC
20.0%
Interest Coverage
9.59x
Current Ratio
0.96x
Dividend Yield
7.6%
Implied Growth (rev. DCF)
1.2%
Rating Score
57/100
Ambev SA (ABEV) is a large-cap company in the Beverages industry, part of the Consumer Staples sector of the S&P 500, with a market value around $51.34B.
In its latest reported year it generated about $17.65B in revenue and $3.10B in net profit.
Our model rates ABEV Neutral (57/100) on growth, profitability, financial health, and valuation. The summary below is built from its filed financials and current ratios and refreshes automatically.
Evidence of durable competitive advantage in the filed financials (10 years of history).
The filed history looks like a business competitors struggle to attack: high and steady margins, revenue that grows through cycles, and strong returns on capital.
51.1% average over the last 3 years
±5.2 pts around 55.3% across 10 years
grew in 8 of the last 9 year-over-year periods
positive in 10 of 10 years
20.0% latest fiscal year
A moat can't be proven by numbers alone — this scores the evidence a durable advantage leaves behind (pricing power, consistency, returns on capital), computed the same way for every stock. Pair it with the business overview before concluding anything.
Technical analysis reads price and volume to judge momentum and timing. It complements the fundamentals above — it does not replace them. Here is what ABEV's chart says today, with each tool explained.
Trend — moving averages. A moving average is the average closing price over a window, which smooths out daily noise. ABEV trades near $3.12, around its 50-day average ($3.14) and 200-day average ($2.76). Price tangled in its moving averages means there is no clear trend — the stock is ranging.
Momentum — RSI. The Relative Strength Index runs 0–100 and measures how strong recent gains are versus losses. Above 70 is "overbought", below 30 "oversold". At 29 it is oversold — selling has been heavy and a bounce is possible.
MACD. MACD compares two moving averages to flag shifts in momentum. Its histogram is currently negative — short-term momentum is fading.
Volatility — ATR. Average True Range is the typical daily move. ABEV's is $0.07 (~2.2% of price), so swings of about that size each day are normal — handy for setting a stop that isn't too tight.
Support & resistance. Over the last month ABEV found buyers near $3.02 (support) and sellers near $3.32 (resistance); its 52-week range is $2.10–$3.45. A decisive break beyond either edge often marks the next move.
Volume. The latest session traded 0.6× the 20-day average — lighter than usual, so the move carries less conviction. Rising volume on up-days suggests real buying; on down-days, real selling.
Educational information to help you read a chart — not a recommendation or a forecast. It updates daily as the price and indicators change.
4Y CAGR
4.9%
Revenue moved from $9.12B in 2016 to $17.65B in 2025, a 7.6% compound annual growth rate. The most recent year declined 3.8% year over year. Shrinking revenue is worth a closer look — is it cyclical or structural?
Gross Margin
51.4%
Operating Margin
26.4%
Net Margin
17.6%
ROE
17.2%
Ambev SA keeps about 17.7% of each sales dollar as net profit, with a 51.4% gross margin and 26.4% operating margin. Return on equity is 17.2% and return on invested capital about 20.0%. Margins this wide usually signal pricing power or a cost advantage.
Total Debt
$443.92M
Net Debt
-$3.28B
Net cash position
Net Debt / EBITDA
-0.7x
Debt / Equity
0.04x
Leverage: debt-to-equity is 0.0x, and operating profit covers interest about 9.6x, with a current ratio of 1.0x. That is a conservative balance sheet — a cushion in downturns. It carries roughly $443.92M of total debt against $3.73B of cash.
Operating CF
$4.89B
Free Cash Flow
$3.97B
FCF Margin
22.5%
In the latest year Ambev SA produced about $4.89B of operating cash flow and $3.97B of free cash flow after capital spending. Cash flow is what ultimately pays shareholders, so it is worth tracking over time.
Can the payout survive a bad year? Scored from filed cash flow, earnings coverage, and the raise/cut record.
The dividend is being paid, but coverage or consistency is thinner than an income investor should rely on without a closer look.
Dividend yield
7.6%
Total paid (latest FY)
$108.78M
History on record
7 years
dividend uses 3% of free cash flow
4% of net income paid out
total dividends increased 1 year in a row
payout was cut at least once in the last 7 years
Coverage uses the latest fiscal year as filed with the SEC; the streak counts total dollars paid (per-share figures can carry split artifacts). Educational information, not income advice.
P/E
16.48x
P/S
2.91x
P/B
2.48x
EV / EBITDA
—
ABEV trades at 16.5x trailing earnings (about 15.2x on estimated forward earnings), 2.9x sales, and 2.5x book value. Reverse-engineering today's price implies the market expects roughly 1.2% long-term free-cash-flow growth. That is a fairly typical valuation for a profitable company.
A two-stage discounted cash flow on real SEC-filed free cash flow — the intrinsic-value anchor professional analysts triangulate from.
DCF fair value / share
$2.77
Current price
$3.12
Starting FCF (latest 10-K)
$3.97B
Growth, years 1–5
-3.8%
Fade to terminal, years 6–10
2.5%
Discount rate
9.0%
Cash flows grow at the stage-1 rate (trailing revenue growth, capped at 20%) for five years, fade to 2.5% by year 10, and continue at that rate forever (Gordon terminal value), all discounted at 9.0%. Small changes in assumptions move the result a lot — treat this as one reference point, not a target price. Educational only, not investment advice.
Where ABEV sits versus its Consumer Staples sector peers in the S&P 500.
Bands show the middle half (25th–75th percentile) of the 48 Consumer Staples companies in the S&P 500 — the peer-relative anchor professional comps analysis uses. Context only — not investment advice.
How ABEV stacks up against its Consumer Staples peers — valuation, profitability, and growth versus the sector median.
In the Consumer Staples sector (74 S&P 500 companies), ABEV ranks #11 of 74 by our overall rating. It trades at a discount versus the sector on earnings (16.5x P/E vs. 22.2x median) with a lower return on equity (17.2% vs. 18.1%) and slower revenue growth (-3.8% vs. 3.4%).
P/E vs sector
16.5x
median 22.2x
ROE vs sector
17.2%
median 18.1%
Growth vs sector
-3.8%
median 3.4%
Sector rank
#11
of 74 by rating
Valuation vs. quality map
The sweet spot is upper-left: more profitable (higher ROE) for a lower P/E. Dashed lines mark the sector median.
Peers are the closest Consumer Staples companies by sub-industry and size. Sector median is across all 74 S&P 500 names in the sector. Educational, not a recommendation.
Project revenue → earnings → price. Edit the assumptions to build your own case.
2030 price target (Base Case)
$0.00 – $0.00
vs. $3.12 today · expected CAGR -6% – 3%
| Metric | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| Revenue | $18.18B | $18.72B | $19.28B | $19.86B | $20.46B |
| Net income | $3.27B | $3.37B | $3.47B | $3.58B | $3.68B |
| EPS | $0.20 | $0.20 | $0.21 | $0.22 | $0.22 |
| Share price (low) | $1.99 | $2.05 | $2.11 | $2.17 | $2.24 |
| Share price (high) | $3.18 | $3.28 | $3.38 | $3.48 | $3.58 |
| CAGR (low–high) | -36% / 2% | -19% / 2% | -12% / 3% | -9% / 3% | -6% / 3% |
Educational model on sample fundamentals — not a forecast or investment advice. Outputs are only as good as your assumptions.
The case for ABEV:
- High net margins (17.7%) point to pricing power or efficiency.
- Strong return on equity (17.2%) shows capital is put to work well.
- A conservative balance sheet (debt/equity 0.0x) lowers risk.
- Pays a 7.6% dividend on top of any price gains.
The case against ABEV:
- Revenue growth is slow/negative (-3.8%), limiting the upside engine.
- Like any single stock, it is exposed to competition, the economic cycle, and shifts in its end markets.
Growth risk — sluggish revenue (-3.8%) leaves little margin for execution missteps.
Market risk — sector rotation, the economic cycle, and broad sentiment move the stock regardless of fundamentals.
On balance, the picture is mixed: Ambev SA is a large-cap consumer staples business with shrinking revenue, with solid profitability, and a sound balance sheet. It trades at 16.5x earnings, which our model scores Neutral (57/100). Weigh this against your own goals and time horizon — this is educational information, not a recommendation.
Analyst Ratings
What 20 Wall Street analysts covering ABEV recommend (July 2026). Consensus is a useful sanity check — not a substitute for your own homework.
Latest SEC Filings
ABEV's most recent filings, straight from SEC EDGAR. Annual and quarterly reports are the deep dives; 8-Ks flag material events the moment they happen.
In the Idea Lab
ABEV — frequently asked questions
Is ABEV a good stock to buy?
We don't give buy or sell advice. Our model rates Ambev SA Neutral (57/100) based on its growth, profitability, financial health, and valuation — use that as a research starting point and make your own decision.
What is ABEV's rating on The Stocks School?
Ambev SA currently scores 57/100 (Neutral) on our transparent model, which weighs real fundamentals: growth, margins, returns on capital, balance-sheet strength, and valuation.
How our ratings work →Where does ABEV's data come from?
Live price data plus real fundamentals and 5-year financials pulled directly from Ambev SA's SEC filings — refreshed automatically, not hand-entered.
How is the 5-year projection for ABEV calculated?
It's a scenario model: it grows revenue at an assumed rate, applies a profit margin and a valuation multiple, and shows the resulting share-price range. The assumptions are yours to change — it's a tool for thinking, not a prediction.
Is this ABEV analysis financial advice?
No. Everything on this page is educational research, not financial advice or a recommendation to buy or sell ABEV. Always do your own research and consider a licensed professional.
Data notice. Fundamentals and financial statements are sourced from company filings (SEC EDGAR) and market-data providers; prices and market caps refresh on trading days and may be delayed. Ratings, projections, technical signals, and written summaries are model- or rule-generated for education and may simplify or lag the latest filings.
Not advice. Nothing on this page is investment advice or a recommendation to buy, hold, or sell any security. Do your own research and consult a licensed financial professional before investing.